Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up have?
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up has 326 citations in the OpenAlex counts ScholarIQ stores.
When was Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up published?
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up has 2024 year in the ScholarIQ index.
What is the open-access status of Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up?
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up has hybrid oa status in the ScholarIQ index.
What is the DOI of Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up?
The DOI for Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up is on the source record.
What is the PMID of Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up?
The PMID for Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up is on the source record.
What is the OpenAlex record for Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up?
The OpenAlex for Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up is on the source record.